| Unternehmen | Marktkap. in Mio. € | Anz. Jahre Outperf. | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DAXsubsector Biotechnology (Perf.) | - | - | +7,62 | +15,50 | +14,27 | +29,75 | +36,09 | +26,77 | -30,80 | -6,28 | -14,91 | +0,33 |
| Sartorius AG Vz | 8.761,68 | 6 | ||||||||||
| Evotec SE | 1.964,70 | 6 | ||||||||||
| Heidelberg Pharma AG | 115,57 | 5 | ||||||||||
| Sartorius AG St | 6.688,54 | 5 | ||||||||||
| Formycon AG | 459,16 | 4 | ||||||||||
| Qiagen NV | 10.007,65 | 3 | ||||||||||
| Pentixapharm Holding AG | 37,17 | 2 | ||||||||||
| BB Biotech AG | 2.458,32 | 2 |